Last updated on December 2018

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.

Clinical Study Identifier: NCT03155997

Contact Investigators or Research Sites near you

Start Over

MA Coccia Portugal

Eastleigh Breast Care Center
Pretoria, South Africa
1.82miles
  Connect »

Coenrad Slabber

Mary Potter Oncology Center
Pretoria, South Africa
1.95miles
  Connect »

Lydia Dreosti

UP- Steve Biko Hospital
Pretoria, South Africa
8.37miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.